polandwaste1
About
Biosimilar infliximab (CT-P13) in the treatment of -inflammatory intestinal condition: A new Norwegian observational study.
Biosimilar infliximab (CT-P13) in the treatment of -inflammatory intestinal condition: A new Norwegian observational study.